Emerging Medical Device Firm Advanced Cooling Therapy Receives License For Commercial Sale Of Its Novel Esophageal Cooling Device In Canada

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CHICAGO--(BUSINESS WIRE)--Emerging medical device manufacturing company, Advanced Cooling Therapy (ACT), has received a license for commercial sale of its first product, the Esophageal Cooling Device (ECD), from Health Canada. The product, which is used to control patient temperature, is now available to medical professionals in Canada.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC